5. Mitchell LE, Adzick NS, Melchionne J, Pasquariello PS, Sutton LN, Whitehead AS. Spina bifida. Lancet. 2004 Nov 20-26;364(9448):1885-95
11. Liu J. The recurrence risk of neural tube defects (NTDs) in a population with high prevalence of NTDs in northern China. Oncotarget. 2017 Sep 22; 8(42): 72577–72583.
12. De-Regil LM, Pena-Rosas JP, Fernandez-Gaxiola AC, Rayco-Solon P. Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane Database of Systematic Review. 2015;12:1465-1858
13. Stanton E. The correlation between maternal diabetes and birth defects. 2015. Available from: https://pdfs.semanticscholar.org/6a90/94b1150bb2b4ead8fdeadabf00f39320ca78.pdf
14. Eadie MJ. Antiepileptic drug safety in pregnancy: possible dangers for the pregnant woman and her foetus. Clinical Pharmacist. 2016
15. Molloy AM. Should vitamin B12 status be considered in assessing risk of neural tube defects?. Ann N Y Acad Sci. 2018;1414(1):109–125
16. Tang KF, Li YL, Wang HY. Quantitative assessment of maternal biomarkers related to one‐carbon metabolism and neural tube defects. Sci. Rep. 2015;5:8510
17. Peker E, Demir N, Tuncer O, et al. The levels of vitamin B12, folate and homocysteine in mothers and their babies with neural tube defects. J. Matern. Fetal Neonatal Med. 2016;29: 2944–2948.
18. Huang HY, Chen HL, Feng LP. Maternal obesity and the risk of neural tube defects in offspring: a meta-analysis. Obes Res Clin Pract. 2017;11(2):188-97
19. Copp AJ, Adzick NS, Chitty LS, Fletcher JM, Holmbeck GN, Shaw GM. Spina bifida. Nat Rev Dis Primers. 2015;1:15007
24. Bhandari J, Thada PK. Neural Tube Disorders. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK555903/